Ultrasonographic Evaluation of Fibrocystic Breast Disease in Patients with Polycystic Ovary Syndrome Polikistik Over Sendromlu Hastalarda Memede Fibrokistik Hastalığın Ultrasonografi İle Değerlendirilmesi


Topbaş Selçuki N. F., Üreyen Özdemir E., Bağci K., Kabakci M., Uzunlulu N., Yalçin Bahat P.

Turkish Journal of Reproductive Medicine and Surgery, cilt.8, sa.2, ss.48-53, 2024 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 2
  • Basım Tarihi: 2024
  • Doi Numarası: 10.24074/tjrms.2023-100320
  • Dergi Adı: Turkish Journal of Reproductive Medicine and Surgery
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.48-53
  • Anahtar Kelimeler: fibrocystic breast disease, Polycystic ovary syndrome, ultrasonography mammary
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective: To evaluate whether polycystic ovary syndrome (PCOS) constitutes an increased risk for benign breast disease by assessing PCOS patients in terms of the presence of fibrocystic breast disease with breast ultrasound assessment. Materials and Methods: This prospective case-controlled study was conducted at a tertiary referral center. Study group consisted of 41 patients who were diagnosed with PCOS according to the Rotterdam criteria. Control group included 41 age-matched patients without any known diseases. All patients received a breast examination with ultrasound and findings were categorized according to BI-RADS. Results: A significantly higher percentage of patients in the study group were categorized as BI-RADS 2 and 3 in comparison to the patients in the control group; 26.8% vs. 9.8%, 9.8% vs. 2.4%, respectively (p < 0.001). Majority of patients in both groups were categorized as BI-RADS 1 and no malignancy or a suspicion of malignancy was reported in both groups. Additionally, a significant difference was observed between the groups in terms of parenchymal pattern (p = 0.02). No parenchymal change was observed in 36.6% of the control group whereas this number was 17.1% in the study group. A significantly higher number of patients with PCOS had fibrocystic breast disease (14.6%) when compared to the control group (2.4%). Conclusion: This study evaluated the association between PCOS and fibrocystic breast disease and the risk of fibrocystic breast disease was found to be higher in patients with PCOS. A routine breast evaluation of PCOS patients with ultrasonography is important for detection of fibrocystic breast disease and for long-term management of these patients.